A pair of biotechnology companies — Viela Bio and NextCure — launched initial public offerings this year, raising nearly $260 million in public funds between them.
Image: Courtesy of Catalyte
{iframe}https://www.bizjournals.com/baltimore/news/2019/10/14/md-tech-exits-heres-who-went-public-got-acquired.html?ana=e_ae_set1&j=84420081&t=Afternoon&mkt_tok=eyJpIjoiWkRBMk1tTm1NRFEzTW1aayIsInQiOiIwUGRNaWRIY2RcLzl4MDdYYlNwbENmQXdHODRKVWZjTmlFeDR4N1cwQ3Y0VndzeDRDRDNMSmN5Q3puUmY0RXBlcjlWYnhmcEVnWHpUeVwvd1FKbW5pcDFURnVFZVhmWWpQNkc1M3J0MFJlXC9pRjZcL0hwK29NcisrT3JUUHFtTU1kSVIifQ%3D%3D{/iframe}